54
Tutorial in Human Hepatocarcinogenesis: Premalignant lesions and stem cells Neil Theise, MD Departments of Pathology and Medicine (Digestive Diseases) Mount Sinai Beth Israel Medical Center New York City Icahn School of Medicine at Mount Sinai

Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)

Embed Size (px)

Citation preview

Page 1: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)

Tutorial in Human Hepatocarcinogenesis:Premalignant lesions and stem cells

Neil Theise, MDDepartments of Pathology and Medicine (Digestive Diseases)Mount Sinai Beth Israel Medical CenterNew York City

Icahn School of Medicine atMount Sinai

Page 2: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)

Nodular dysplasias• Hepatocellular adenomas• Dysplastic nodules (only in CLD)

Cellular dysplasias• Small cell change• Large cell change

Page 3: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)

Distinctive nodules which differ from the surrounding parenchyma in terms of:

size,color,texture, or degree of bulging from the cut surface…

Dysplastic Nodules

Page 4: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)
Page 5: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)
Page 6: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)
Page 7: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)
Page 8: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)

Distinctive nodules which differ from the surrounding parenchyma in terms of:

size,color,texture, or degree of bulging from the cut surface…

…AND contain portal tracts.

Dysplastic Nodules

Page 9: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)
Page 10: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)

Low GradeDysplasticNodules

Page 11: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)

Features of Low Grade DNs:

Normal cytology or

Large cell change only

No architectural atypia

Page 12: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)
Page 13: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)
Page 14: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)

High GradeDysplasticNodules

Page 15: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)

Features of High Grade DNs:

Cytologic atypia e.g. small cell change

Clone-like domains e.g. Mallory body clustering, fatty or clear cell change, iron resistance, etc.

Architectural atypia e.g. pseudogland formation

Page 16: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)
Page 17: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)
Page 18: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)
Page 19: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)
Page 20: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)

Incidence of DNs in Cirrhotic Livers

Location Source # Cirrhotic Livers

# w/ DNs (%)

Tokushima Autopsy 315 46 (14%)

New York Explant 44 11 (25%)

San Francisco Explant 110 17 (15%)

Kanazawa Autopsy 209 45 (21%)

New York Explant 155 32 (22%)

Bordeaux Explant 41 10 (24%)

Page 21: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)

Chronic HepatitisHepatitis B and C Autoimmune hepatitis

Metabolic DiseaseGenetic hemochromatosis A-1-AT Deficiency

Chronic Biliary Tract Disease PBC, PSC

Toxic InjuryChronic alcoholic liver injury

Page 22: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)
Page 23: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)
Page 24: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)
Page 25: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)

Chronic hepatitis

with fibrosis10-50 years

Natural History of Chronic Liver Disease

Cirrhosis

Normal liver

HepatocellularCarcnoma

Page 26: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)

Increased proliferation

NodularHCC

Low gradedysplastic

nodule

Dysplasticnodule

containing early HCC

Genetic alteration

High gradedysplastic

nodule

Old Model

Page 27: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)

Chronic hepatitis

with fibrosis10-50 years

Natural History of Chronic Liver Disease

Cirrhosis

Normal liver

HepatocellularCarcnoma

Page 28: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)
Page 29: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)
Page 30: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)
Page 31: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)
Page 32: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)
Page 33: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)
Page 34: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)
Page 35: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)
Page 36: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)
Page 37: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)
Page 38: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)
Page 39: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)
Page 40: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)

SPREADINGMONOCLONAL

PROLIFERATION

CLONALDYSPLASTIC NODULE

DEVELOPING CIRRHOSIS

DIMINISHED HSC ACTIVATION

Page 41: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)

SPREADINGMONOCLONAL

PROLIFERATION

NODULE-IN-NODULELESION

CLONALDYSPLASTIC NODULE

DEVELOPING CIRRHOSIS

DIMINISHED HSC ACTIVATION

Page 42: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)

SPREADINGMONOCLONAL

PROLIFERATION

NODULE-IN-NODULELESION

CLONALDYSPLASTIC NODULE

DEVELOPING CIRRHOSIS

DIMINISHED HSC ACTIVATION

MATUREHEPATOCELLULAR

CARCINOMA

Page 43: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)

Aihara T, et al.Clonal analysis of regenerative nodules in

hepatitis C virus-induced liver cirrhosis.Gastroenterology 1994; 107: 1805-11.

Page 44: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)
Page 45: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)

XX

XX X

X

X

X

X

X

X

Page 46: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)

XX

XX I

I

I

I

I

I

X

Page 47: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)

IIII

IIII I

I

I

I

I

I

II

Page 48: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)

IIII

II

Page 49: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)
Page 50: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)

SPREADINGMONOCLONAL

PROLIFERATION

NODULE-IN-NODULELESION

CLONALDYSPLASTIC NODULE

DEVELOPING CIRRHOSIS

DIMINISHED HSC ACTIVATION

MATUREHEPATOCELLULAR

CARCINOMA

NL or INCREASED HSC ACTIVATION

Page 51: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)

SPREADINGMONOCLONAL

PROLIFERATION

NODULE-IN-NODULELESION

CLONALDYSPLASTIC NODULE

DEVELOPING CIRRHOSIS

DIMINISHED HSC ACTIVATION

MATUREHEPATOCELLULAR

CARCINOMA

ADJACENT CLONAL CIRRHOTIC NODULES

NL or INCREASED HSC ACTIVATION

Page 52: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)

SPREADINGMONOCLONAL

PROLIFERATION

NODULE-IN-NODULELESION

CLONALDYSPLASTIC NODULE

DEVELOPING CIRRHOSIS

DIMINISHED HSC ACTIVATION

MATUREHEPATOCELLULAR

CARCINOMA

ADJACENT CLONAL CIRRHOTIC NODULES

MULTIPLE, ADJACENTOr

DNs w/ INDISTINCT BORDERSMICROSCOPIC HCCs

NL or INCREASED HSC ACTIVATION

Page 53: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)

Early HCC, vaguely nodular type

Early HCC, distinctly nodular type

Page 54: Tutorial in Human Hepatocarcinogenesis, Part 1 (pre-malignant lesions)

Hepatology 2009; 49: 658